CIPO Patents = 3

EPO Patents = 13

Trademarks = 5

Forward Citations = 5

Loading Chart...

3 inventors (with patents filed for the assignee):

Stephen Patrick O'Hara (10 out of 14 patents)

Sofia Kolida (4 out of 4 patents)

Robert Rastall (2 out of 10 patents)

4. Oswaldo Hernandez (2 out of 2 patents)

5. Stephen Patrick O'hara (1 patent)

10 patents: Sort by Forward Citations

1. 12213501 - Methods for modifying high intensity sweetener glycosides (2025-02-04),

2. 12042506 - Prebiotic compositions and methods of production thereof (2024-07-23),

3. 12023360 - Composition and methods of screening (2024-07-02),

4. 11622980 - Compositions comprising prebiotics and probiotics (2023-04-11),

5. 11173170 - Prebiotic composition and its methods of production (2021-11-16),

6. 10898528 - Composition comprising2830 (ECGC 13110402) (2021-01-26),

7. 10863763 - Prebiotic compositions and uses thereof (2020-12-15),

8. 10645965 - Dietary composition with probiotics and prebiotics (2020-05-12),

9. 10463704 - Composition comprising (2019-11-05),

10. 9913857 - Composition and methods of screening (2018-03-13),

Optibiotix Limited is a life sciences company developing compounds to tackle obesity, high cholesterol, and diabetes. Their products are based on the science of the microbiome and have shown promising results in clinical trials. Optibiotix is committed to improving human health through innovative solutions.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

10 Patents

#4 in Yorkshire

#1,730 in United Kingdom

#55,954 in the World

Yorkshire, United Kingdom

Optibiotix Limited

Forward Citations = 5

3 inventors:

Stephen Patrick O'Hara (10 out of 14 patents)

Sofia Kolida (4 out of 4 patents)

Robert Rastall (2 out of 10 patents)

4. Oswaldo Hernandez (2 out of 2 patents)

5. Stephen Patrick O'hara (1 patent)

Please report any incorrect information to [email protected]

3 patents (CIPO):

Please report any incorrect information to [email protected]

13 patents (EPO):

Please report any incorrect information to [email protected]